The neurotherapeutic role of a selenium-functionalized quinoline in hypothalamic obese rats.

Karline C RodriguesCristiani F BortolattoKetlyn P da MottaRenata L de OliveiraJaini J PaltianRoberta KrügerSilvane S RomanSilvana P BoeiraDiego AlvesEthel Antunes WilhelmCristiane Luchese

Published in: Psychopharmacology (2021)

In brief, 4-PSQ therapy improved hypothalamic obesity-related parameters, as well as psychiatric symptoms, cognitive impairment, and neurochemical alterations found in obese rats.

Keyphrases

weight loss
metabolic syndrome
cognitive impairment
type diabetes
adipose tissue
insulin resistance
bariatric surgery
obese patients
mental health
molecular docking
quantum dots
stem cells
body mass index
sleep quality
bone marrow
cell therapy
high resolution